In the modern world, Dimetindene is a topic that has gained great relevance in recent years. In both the business and personal spheres, Dimetindene is a determining factor that influences multiple aspects of daily life. With the advancement of technology and social changes, Dimetindene has become a topic of constant debate, generating conflicting opinions and deep reflections on its impact on society. In this article, we will explore different perspectives and analyzes on Dimetindene, with the goal of better understanding its influence on our current reality.
![]() | |
Clinical data | |
---|---|
Trade names | Fenistil |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.622 |
Chemical and physical data | |
Formula | C20H24N2 |
Molar mass | 292.426 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Dimetindene, also sold under the brand name Fenistil, is an antihistamine/anticholinergic. It is a first generation[1] selective H1 antagonist.[2] Dimetindene is an atypical first generation H1 antagonist as it only minimally[3] passes across the blood–brain barrier.
Dimetindene is also an M2 receptor antagonist.[4]
It was patented in 1958 and came into medical use in 1960.[5]
Dimetindene is used orally and topically as an antipruritic.[6] It is used topically to treat skin irritations, such as insect bites. Dimetindene is also administered orally to treat allergies, such as hay fever.
It is commonly formulated as its maleic acid salt, dimethindene maleate.
It is sold under the brand name Fenistil among others.